Top Tweets for #CSTONE
According to documents disclosed by #HKSE, on August 18, the Government of Singapore Investment Corporation (GIC), a sovereign wealth fund, increased its stake in 🇨🇳 #CStone, a biotech listed on the HKEX 18A sector, by acquiring a total of 80.4 million ordinary shares at an average price of HK$7.9 per share, with a total value of approximately HK$635 million. Following this acquisition, GIC's shareholding in CStone rose from 0.00% to 5.49%.
Fantastic to meet Yucheng Sheng again in Shanghai during my transit. This was 2nd time meeting him after our time at @School_Pharmacy! He is now a Senior Director in #CSTONE Pharmaceutical! Great to know his success in industry & his endless passion in #pharmaceuticalscience!
🇨🇳 #CStone Pharmaceuticals announced an exclusive partnership with Istituto Gentili, a leading European biopharmaceutical company with a century-long heritage in oncology, to commercialize #sugemalimab across Western Europe and the UK. https://t.co/o1ITRPi2MV
Gentili will receive exclusive commercialization rights for sugemalimab in 23 European countries.
CStone is eligible to receive up to US$192.5 million in total consideration, comprising an upfront payment and payments tied to regulatory and commercial milestones. Additionally, CStone will supply sugemalimab and recognize close to 50% of net sales from the licensed territories as revenue, while Gentili will lead all local regulatory and commercial operations in the covered regions.
🇨🇳 #CStone Pharma announced today that the global multicenter Phase I/II study of #CS2009, a potential first-in-class/best-in-class PD-1/VEGF/CTLA-4 #trispecific #antibody independently developed by CStone, is actively enrolling patients in Australia and China, with planned expansion to the United States for Phase II enrollment. https://t.co/0D7auwpypq
Recently, a PCT patent of 🇨🇳 #Zelgen's PD-L1/VEGF/CCR8 trispecific antibody (WO2025140619).
To date, 4 PD-1(L1)/VEGF trispecific antibody drugs have entered clinical trials, including 2 PD-1/VEGF/CTLA-4 antibodies and 2 PD-L1/VEGF/TGFβ antibodies. (Source: UmabsDB)
PD-1/VEGF/CTLA-4:
-HC 010 (🇨🇳 HC Biopharma, Ph1)
-CS 2009 (🇨🇳 CStone, Ph1)
-GB 268 (🇨🇳Genor Biopharma, IND submission)
PD-L1/VEGF/TGFβ
-PM8003 (🇨🇳 Biotheus, Ph1 discontinued)
-DR30206 (🇨🇳 Doer Biologics, Ph1)
-Q 1806 (🇨🇳 QureBio, Preclinical)
PD-L1/VEGF/HER2
-(🇨🇳 Sanyou Bio, patent public)
PD-L1/VEGF/CCR8
-(🇨🇳 Zelgen, patent public)
1/2
想要1魚多吃的朋友，現在手續費下降了，適合小資族 ~
本次以質押在 #Zircuit 為例(未發幣)：
step1
先去 #stakestone 網站去claim #cSTONE (手續費7.5U)
step2
再去zircuit網站(https://t.co/5q4LcKaD5q)去Stake cSTONE
這裡同時如果有pufETH的朋友可以一起質押
CStone to present the latest clinical results of anti-PD-L1 antibody Sugemalimab at ASCO 2022.
#cstone #medical #Sugemalimab #ASCO #biopharmaceutical #health #healthcare #antibody #therapies #research #development #cstonepharmaceuticals
https://t.co/FXPDyMYGzJ
https://t.co/RPVQyithn6
#世界肺癌大会亮点一文总结：安进、阿斯利康、罗氏、和黄医药、基石药业等公布最新结果
Highlights of the #WorldLungCancerConference Summary: #Amgen, #AstraZeneca, #Roche, #Chi-Med, #CStone, etc. announce the latest results
#WCLC2022
NSCLSの一次治療において、#Cstone 社/#EQRX 社 #sugemalimab と #Shanghai Junshi社/#Coherus 社 #toripalimabは承認可能な抗PD-(L)1プロジェクトを持っているかもしれないが、価格面で #Merck 社の #Keytruda に対抗できるかが鍵だ。
https://t.co/ZlJeImRRqn
#Evaluate
#CStone announces clinical data of #sugemalimab in patients with stage III non-small cell lung #cancer selected as late-breaking abstract for oral presentation at ESMO Congress 2021; #OmniAb https://t.co/pH0EoHBRtD
CStone Enters $1 Billion Deal with EQRx to Advance Immunotherapy Agents
#biospace #lifesciences #biotechnology #pharmaceuticals #CStone #immunotherapy
https://t.co/rXmkyIEsj9
Demiurge AI-based #clinicaltrials outcome predictions made on February 05 2020 put to the public test (028_2020):
SUCCESS for
#spartalizumab / NCT03728556 / #CStone
@GICGroup @Fidelity @TRowePrice
Big moves in Management Tracks in @BioCentury today. @SusanDesmondH15 ; #CStone nabs ex @bmsnews exec; @JanssenUS gets @US_FDA alum, and more.https://t.co/jb4pyI3f5r
#WeeklyinAsia 2019｜JULY
1/ The 21st #INTERPHEX Week Japan 2019 Concludes on a Successful Note
2/ #CStone Announces Global Collaboration with @BayerPharma on Combination Therapy for Cancer
3/ @MacroGenics and #IMab..........
https://t.co/lBnQCbpY9k
Last Seen Hashtags on Sotwe
gachabadending
Seen from Thailand
ensest
Seen from Turkey
dogs
Seen from United States
AlterUST
Seen from Norway
outdoor trans
Seen from Turkey
ควย60
Seen from Thailand
teen
Seen from Germany
momson((()))************************************************************************************* filter:videos
Seen from United States
tekirdagtravesti
Seen from Turkey
party
Seen from Thailand
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.1M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
87.9M followers
Taylor Swift
@taylorswift13
81.8M followers
Lady Gaga
@ladygaga
73.3M followers
Virat Kohli
@imvkohli
70.3M followers
Kim Kardashian
@kimkardashian
69.9M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64M followers
Neymar Jr
@neymarjr
63.1M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61M followers
X
@x
60.8M followers